RETRACTED: ORIENT-3: A randomized, open-label, phase III study of sintilimab versus docetaxel in previously treated advanced/metastatic squamous non-small cell lung cancer (sqNSCLC).
Ann Oncol. 2020 Dec;31 Suppl 7:S1428. doi: 10.1016/j.annonc.2020.10.517. Epub 2020 Dec 13.
Ann Oncol. 2020.
PMID: 33517977